Genomics Growth Boosts NGS Informatics Market to $4.3 Billion by 2030

Deeya5220

posted on 3 weeks ago — updated on 1 second ago

20
views

Genomics Growth Boosts NGS Informatics Market to $4.3 Billion by 2030

Explore $4.3 billion Next Generation Sequencing (NGS) Informatics Market: Get exclusive insights on key market trends, segments, geographical analysis, & competitive analysis

: NGS Informatics Market Analysis

Meticulous Research® has published an in-depth report titled “Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation & Reporting, Storage & Computing, LIMS), Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030.” According to this report, the NGS informatics market is expected to reach $4.3 billion by 2030, with a CAGR of 15.4% throughout the forecast period. The key drivers of this growth include rising investments in R&D from pharmaceutical and biotech companies, an increase in cancer and genetic disorders, and expanding applications of NGS in diagnostics and precision medicine. Technological advancements and government initiatives supporting large-scale genomic sequencing projects also contribute positively, though challenges related to data privacy remain.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3483

The rising adoption of NGS informatics tools in clinical laboratories creates opportunities for bioinformatics and genomic data management solutions. However, a lack of skilled professionals proficient in NGS informatics tools continues to hinder market growth.

Market Segmentation Overview

The NGS informatics market is categorized by offering, including software (data analysis, interpretation, reporting, storage, and LIMS), deployment mode (web/cloud-based and on-premise), applications (diagnostic, drug discovery, precision medicine, biomarker discovery, agriculture, and animal research), end users (pharmaceutical and biotechnology companies, hospitals, diagnostic labs, and academic institutions), and geographic regions. The report provides a comprehensive analysis of industry competitors and market dynamics at regional and country levels.

In 2023, the software segment is expected to capture the largest market share due to its capacity to efficiently process and manage extensive genomic datasets, aligning with the growing need for scalable data storage solutions.

The drug discovery segment is anticipated to dominate the NGS informatics market in 2023, driven by reduced sequencing costs and the ability of NGS to identify numerous genetic mutations.

Pharmaceutical and biotechnology companies are expected to lead the market share among end users in 2023, driven by increased R&D activities, outsourcing of projects, and a trend toward using genomic technologies.

Regional Insights

The report also highlights key geographic markets, focusing on North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and other countries), Asia-Pacific (China, Japan, India, and the wider Asia-Pacific region), Latin America (Brazil, Mexico, and the rest of Latin America), and the Middle East & Africa.

In 2023, North America is projected to represent the largest share of the NGS informatics market, followed closely by Europe and Asia-Pacific. The U.S. is anticipated to dominate the North American market due to heightened R&D spending, the presence of leading NGS informatics companies, supportive government policies, and a favorable reimbursement landscape for NGS testing.

Conclusion

The NGS informatics market is positioned for substantial growth, fueled by advancements in technology, increasing investments in research, and the expanding use of NGS across multiple applications. Despite challenges related to data security and workforce shortages, the overall outlook remains positive, presenting numerous opportunities for innovation and market expansion.

Browse in Depth : https://www.meticulousresearch.com/product/ngs-informatics-market-3483

Key Players

The key players operating in the next generation sequencing (NGS) informatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.).

Key questions answered in the report:

Which are the high-growth market segments in terms of offering, application, end user, and region/country?
What was the historical market size for next generation sequencing (NGS) informatics across the globe?
What are the market forecasts and estimates for the period 2023–2030?
What are the major drivers, restraints, challenges, and opportunities in the global next generation sequencing (NGS) informatics market?
Who are the major players in the global next generation sequencing (NGS) informatics market?
How is the competitive landscape, and who are the market leaders in the global next generation sequencing (NGS) informatics market?
What are the recent developments in the next generation sequencing (NGS) informatics market?
What are the different strategies adopted by the major players in the next generation sequencing (NGS) informatics market?
What are the geographical trends and high growth regions/countries?